Cargando…

Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan

Objectives. Accumulation of extracellular matrix (ECM) components is an early sign of diabetic nephropathy. Also the glycosaminoglycan hyaluronan (HA) is elevated in the renal interstitium during experimental diabetes. The mammalian target of rapamycin (mTOR) pathway participates in the signaling of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stridh, Sara, Palm, Fredrik, Takahashi, Tomoko, Ikegami-Kawai, Mayumi, Hansell, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816883/ https://www.ncbi.nlm.nih.gov/pubmed/26175092 http://dx.doi.org/10.3109/03009734.2015.1062442

Ejemplares similares

Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin
por: Stridh, Sara, et al.
Publicado: (2017)

Inhibition of hyaluronan synthesis in rats reduces renal ability to excrete fluid and electrolytes during acute hydration
por: Stridh, Sara, et al.
Publicado: (2013)

Roles of glomerular endothelial hyaluronan in the development of proteinuria
por: Asai, Akimasa, et al.
Publicado: (2021)

Delayed mTOR Inhibition with Low Dose of Everolimus Reduces TGFβ Expression, Attenuates Proteinuria and Renal Damage in the Renal Mass Reduction Model
por: Kurdián, Melania, et al.
Publicado: (2012)

Role of carbonic anhydrase in acute recovery following renal ischemia reperfusion injury
por: Nensén, Oskar, et al.
Publicado: (2019)

Targeting hyaluronan accumulation in the tumor microenvironment
por: Li, Xiaoming, et al.
Publicado: (2018)

Optimising the use of mTOR inhibitors in renal transplantation
por: Russ, Graeme R
Publicado: (2013)

Decreased mTOR signalling reduces mitochondrial ROS in brain via accumulation of the telomerase protein TERT within mitochondria
por: Miwa, Satomi, et al.
Publicado: (2016)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation
por: Hartwig, Pia, et al.
Publicado: (2021)

Accumulation of Extracellular Hyaluronan by Hyaluronan Synthase 3 Promotes Tumor Growth and Modulates the Pancreatic Cancer Microenvironment
por: Kultti, Anne, et al.
Publicado: (2014)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR inhibitor everolimus reduces invasiveness of melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2019)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
por: Esfahani, Khashayar, et al.
Publicado: (2019)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015)

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
por: Ghosh, Arindam P., et al.
Publicado: (2015)

Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
por: Li, Yuhong, et al.
Publicado: (2020)

mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients
por: Jefferies, Reece, et al.
Publicado: (2022)

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
por: Nykopp, Timo K, et al.
Publicado: (2010)

Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts: CONTRIBUTORY ROLE IN HYALURONAN ACCUMULATION IN THYROID DYSFUNCTION
por: Zhang, Lei, et al.
Publicado: (2009)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

The role of hyaluronan in renal cell carcinoma
por: Jin, Chenchen, et al.
Publicado: (2023)

Hyaluronan Accumulates With High-Fat Feeding and Contributes to Insulin Resistance
por: Kang, Li, et al.
Publicado: (2013)

Effects of propofol on LC3II and mTOR/p-mTOR expression during ischemia-reperfusion myocardium injury in rats with type 2 diabetes mellitus
por: Wang, Ying, et al.
Publicado: (2020)

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR
por: Maiese, Kenneth
Publicado: (2016)

Inhibition of mTOR Reduces Anal Carcinogenesis in Transgenic Mouse Model
por: Sun, Zhi-Jun, et al.
Publicado: (2013)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Double agent mTOR
por: Danzer, Steve C.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

Iodinated contrast media inhibit oxygen consumption in freshly isolated proximal tubular cells from elderly humans and diabetic rats: Influence of nitric oxide
por: Liss, Per, et al.
Publicado: (2016)

Monitoring for proteinuria in patients with type 2 diabetes mellitus
por: Liang, Huifang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j296kkkju3qfvotib04dkr819t